Caligan Partners LP
- SEC CIK
- 0001727492
- Latest filing
- Aug 14, 2026
MLYS holding history
Mineralys Therapeutics, Inc. in every 13F filed by Caligan Partners LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLYS overviewAll 13F holders of MLYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −2,772,654−100.0% | Sold out | Holders |
| Q1 2026 | 2,772,654 | $75.1M | 5.3% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,772,654 | $100.6M | 9.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,772,654 | $105.1M | 14.6% | +755,302+37.4% | Added | Holders |
| Q2 2025 | 2,017,352 | $27.3M | 5.3% | −132,315−6.2% | Reduced | Holders |
| Q1 2025 | 2,149,667 | $34.1M | 7.1% | +1,138,512+112.6% | Added | Holders |
| Q4 2024 | 1,011,155 | $12.4M | 3.2% | +30,000+3.1% | Added | Holders |
| Q3 2024 | 981,155 | $11.9M | 3.8% | +235,397+31.6% | Added | Holders |
| Q2 2024 | 745,758 | $8.73M | 2.0% | +745,758 | New | Holders |